Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Cohen, IL
Alan P. Cohen, Palatine, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100081851 | ADSORBENT FOR DRYING ETHANOL - This invention involves the use of a more effective adsorbent to dehydrate ethanol. The most common use for the ethanol is an additive to gasoline. The preferred adsorbent is a type 3A adsorbent that has been ion exchanged with potassium at a level of about 0.6. Surprisingly, this adsorbent has a significantly improved resistance to damage by water upset events. | 04-01-2010 |
Amy Cohen, Grayslake, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110091427 | METHODS FOR TREATING A KIDNEY INJURY - Provided herein are methods of treating a kidney injury in a patient, comprising administering to the patient hematopoietic stem cells (HSCs) in an amount effective to treat the kidney injury. In some embodiments, administration of the HSCs is delayed, such that the HSCs are not administered immediately after the kidney injury. In certain aspects, the HSCs are administered to the patient during the beginning of the repair phase of the kidney. Further embodiments and aspects of the invention, including related methods and compositions for use therein, are described herein. | 04-21-2011 |
| 20110274667 | METHODS FOR OBTAINING CELL POPULATIONS FROM ADIPOSE TISSUE - Provided herein are methods of efficiently obtaining large numbers of viable, freshly isolated cells from small amounts of adipose tissue, as well as methods of enriching or selecting for target cell populations found therein. In certain embodiments, the method of obtaining a population of cells from adipose tissue comprises incubating the adipose tissue in a solution comprising an enzyme at a concentration which is at least 200 U/ml solution and not more than about 319 U/ml solution. In some embodiments, the method is devoid of any steps which expand the population of cells obtained. In certain aspects, the method further comprises positive or negative selection steps for obtaining an enriched population of target cells from adipose tissue. Related methods of preparing a pharmaceutical composition comprising cells for administration to a patient and methods of treating a disease or medical condition in a patient are further provided herein. | 11-10-2011 |
Brian Aian Cohen, Wilmette, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110019952 | Self-Aligning Maintenance Free Bearing Unit for Agricultural Applications - A contamination-resistant bearing assembly includes an outer ring mounted within a housing and an inner ring rotatably supported from the outer ring. Inboard and outboard seal structures are disposed within a bearing space defined between the rings and prevent contaminants from entering a rolling element lubrication zone. A surface seal may also be included to protect the spherical interface between the housing and outer ring. The improved structure allows dynamic alignment of the bearing assembly when acted on by outside forces and also allows for extended operation under maintenance free conditions with no need for relubrication. | 01-27-2011 |
Edward P. Cohen, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080305131 | Cancer Immunotherapy with Semi-Allogeneic Cells - The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual. | 12-11-2008 |
| 20090214494 | Cancer Vaccines and Therapeutic Methods - Compositions and methods of producing improved cancer vaccines are described. In addition, methods of identifying tumor associated antigens are also described. | 08-27-2009 |
| 20110014241 | Therapeutic Cancer Antigens - The present invention relates to cells, pharmaceutical compositions, tumor vaccines, kits and methods for inhibiting cell proliferation or tumor growth in a mammal, specifically, the invention relates to cells that express a tumor-associated tumor antigen. | 01-20-2011 |
Eli Cohen, Skokie, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090112483 | Protocol For Risk Stratification of Ischemic Events and Optimized Individulaized Treatment - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject. | 04-30-2009 |
| 20090208988 | Protocol and Apparatus for Determining Heparin-induced Thrombocytopenia - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II). | 08-20-2009 |
| 20100041081 | Protocol For Risk Stratification of Ischemic Events and Optimized Individualized Treatment - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject. | 02-18-2010 |
| 20110117586 | Protocol for Risk Stratification of Ischemic Events and Optimized Individualized Treatment - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject. | 05-19-2011 |
Jason Cohen, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110131142 | Patent-Product Information Distribution Systems and Methods - Systems and methods for managing and distributing patent-product information are presented herein. The systems and method facilitate the exchange of patent-product information, by performing the steps of: a) receiving patent-product information from a plurality of users; b) storing the patent-product information in a patent-product database on a server, in accordance with an input hierarchy; c) receiving a demand query from a public user, based on an identification marker; d) searching the patent-product database and obtaining patent-product information responsive to the public user's demand query; and e) delivering the obtained patent-product information to the public user. | 06-02-2011 |
| 20110131143 | Patent-Product Information Distribution Systems and Methods - Systems and methods for managing and distributing patent-product information are presented herein. The systems and method may facilitate the exchange of patent-product information, by performing the steps of: a) receiving patent-product information from a plurality of users; b) storing the patent-product information in a patent-product database on a server, in accordance with an input hierarchy; c) receiving a demand query from a public user, based on an identification marker; d) searching the patent-product database and obtaining patent-product information responsive to the public user's demand query; and e) delivering the obtained patent-product information to the public user. The systems and methods also provide for automatically issuance of an alert to a previously-specified recipient at a previously-specified time before expiration of a patent associated with the patent-product information. | 06-02-2011 |
Joel Cohen, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20120116945 | Method and System for Displaying and Trading Spreads - A trading application can receive price and quantity information for tradeable objects. The trading application can compute implied price and quantity information for spreads of the tradeable objects. Direct and indirect price and quantity information for the spreads can be displayed in a manner that shows the relationship with each other and with the price and quantity information for the tradeable objects. | 05-10-2012 |
Jon Cohen, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090249584 | CHARM INSERTER - A charm inserter includes a first restraining end spaced apart from a second restraining end and a charm end. The charm end connects on a first side to the first restraining end and on a second side to the second restraining end. The first side is non-parallel and non-perpendicular with the second side, and the charm end includes a first portion, second portion, third portion, fourth portion, and fifth portion. | 10-08-2009 |
Michael Aaron Cohen, Buffalo Grove, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110311052 | Wireless Device Enabled Locking System - An encrypted security system and associated methods for controlling physical access. The system includes a security server configured to receive a request for authentication from a mobile device, the request comprising information identifying the mobile device and a physical access control device. The security server forwards an encryption message comprising a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism. | 12-22-2011 |
Roslyn Cohen, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090208988 | Protocol and Apparatus for Determining Heparin-induced Thrombocytopenia - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II). | 08-20-2009 |
Steven A. Cohen, Naperville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090191101 | CATALYST AND SYSTEMS INCORPORATING THE CATALYST - A catalyst includes a carrier body and a catalytic portion carried by the carrier body. The catalytic portion includes a plurality of distinct layers of catalytic material, which layers may be deposited through atomic layer deposition techniques. The catalyst may have a selectivity for the conversion of alkanes to alkenes of over 50%. The catalyst may be incorporated in a reactor such as a fluidized bed reactor or a single pass reactor. | 07-30-2009 |
| 20100331563 | Chain growth reaction process - A process is disclosed for the preparation of zinc alkyl chain growth products via a catalysed chain growth reaction of an alpha-olefin on a zinc alkyl, wherein the chain growth catalyst system employs a group 3-10 transition metal, or a group 3 main group metal, or a lanthanide or actinide complex, and optionally a suitable activator. The products can be further converted into alpha-olefins by olefin displacement of the grown alkyls as alpha-olefins from the zinc alkyl chain growth product, or into primary alcohols, by oxidation of the resulting zinc alkyl chain growth product to form alkoxide compounds, followed by hydrolysis of the alkoxides. | 12-30-2010 |
| 20110113679 | METHODS OF REFINING AND PRODUCING FUEL FROM NATURAL OIL FEEDSTOCKS - Methods are provided for refining natural oil feedstocks. The methods comprise reacting the feedstock in the presence of a metathesis catalyst under conditions sufficient to form a metathesized product comprising olefins and esters. In certain embodiments, the methods further comprise separating the olefins from the esters in the metathesized product. In certain embodiments, the methods further comprise hydrogenating the olefins under conditions sufficient to form a fuel composition. In certain embodiments, the methods further comprise transesterifying the esters in the presence of an alcohol to form a transesterified product. | 05-19-2011 |
| 20110230687 | METHODS OF PRODUCING JET FUEL FROM NATURAL OIL FEEDSTOCKS THROUGH OXYGEN-CLEAVED REACTIONS - Methods are provided for producing a jet fuel composition from a feedstock comprising a natural oil. The methods comprise reacting the feedstock with oxygen under conditions sufficient to form an oxygen-cleaved product. The methods further comprise hydrogenating the oxygen-cleaved product under conditions sufficient to form a jet fuel composition. | 09-22-2011 |
| 20110237850 | METHODS OF PRODUCING JET FUEL FROM NATURAL OIL FEEDSTOCKS THROUGH METATHESIS REACTIONS - Methods are provided for producing a jet fuel composition from a feedstock comprising a natural oil. The methods comprise reacting the feedstock with a low-weight olefin in the presence of a metathesis catalyst under conditions sufficient to form a metathesized product. The methods further comprise hydrogenating the metathesized product under conditions sufficient to form a jet fuel composition. | 09-29-2011 |
Steven Alan Cohen, Naperville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080200709 | Chain growth reaction process - A process is disclosed for the preparation of zinc alkyl chain growth products via a catalysed chain growth reaction of an alpha-olefin on a zinc alkyl, wherein the chain growth catalyst system employs a group 3-10 transition metal, or a group 3 main group metal, or a lanthanide or actinide complex, and optionally a suitable activator. The products can be further converted into alpha-olefins by olefin displacement of the grown alkyls as alpha-olefins from the zinc alkyl chain growth product, or into primary alcohols, by oxidation of the resulting zinc alkyl chain growth product to form alkoxide compounds, followed by hydrolysis of the alkoxides. | 08-21-2008 |
| 20080200715 | PROCESS FOR THE AMMOXIDATION OF PROPANE AND ISOBUTANE - A process for the ammoxidation of a saturated or unsaturated or mixture of saturated and unsaturated hydrocarbon to produce an unsaturated nitrile, said process comprising contacting the saturated or unsaturated or mixture of saturated and unsaturated hydrocarbon with ammonia and an oxygen-containing gas in the presence of a catalyst composition comprising molybdenum, vanadium, antimony, niobium, tellurium, optionally at least one element select from the group consisting of titanium, tin, germanium, zirconium, hafnium, and optionally at least one lanthanide selected from the group consisting of lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, dysprosium, holmium, erbium, thulium, ytterbium and lutetium. Such catalyst compositions are effective for the gas-phase conversion of propane to acrylonitrile and isobutane to methacrylonitrile (via ammoxidation). | 08-21-2008 |
| 20080200716 | Mixed metal oxide catalysts for the ammoxidation of propane and isobutane - A process for the ammoxidation of a saturated or unsaturated or mixture of saturated and unsaturated hydrocarbon to produce an unsaturated nitrile, said process comprising contacting the saturated or unsaturated or mixture of saturated and unsaturated hydrocarbon with ammonia and an oxygen-containing gas in the presence of a catalyst composition comprising molybdenum, vanadium, antimony, niobium, tellurium, optionally at least one element select from the group consisting of titanium, tin, germanium, zirconium, hafnium, and optionally at least one lanthanide selected from the group consisting of lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, dysprosium, holmium, erbium, thulium, ytterbium and lutetium. Such catalysts are characterized by very low levels of tellurium in the composition. Such catalyst compositions are effective for the gas-phase conversion of propane to acrylonitrile and isobutane to methacrylonitrile (via ammoxidation). | 08-21-2008 |